← Human Trials & Peer-Reviewed Studies
Repeated Heat Stress Modulates the Levels of the Mitokines MOTS-C and FGF21 in Active Men during Calf Muscle Immobilization
Plain-language guide to PMID 40674654 (2025): randomized controlled trial study of MOTS-c in 19 men.
Key Facts
- PMID
- 40674654
- Journal
- Medicine and science in sports and exercise
- Year
- 2025
- Study type
- Randomized Controlled Trial
- Authors
- Elhusseiny R et al. (14 authors)
- DOI
- 10.1249/MSS.0000000000003825
What This Study Did, in Plain Language
What Was Tested
The paper reports a study of MOTS-c, published as a randomized controlled trial.
This study thus investigated the effect of repeated heat exposures on mitokine response in the context of immobilization-induced muscle atrophy.
Who Took Part
According to the abstract, 19 men were involved.
PubMed indexes the participants as young adults and adults, men only.
A total of 19 physically active men underwent 4 wk of supervised training followed by 2 wk of immobilization of the left ankle, during which they were randomly divided into the heat ( n = 9) or the sham ( n = 10) treatment group.
How the Study Was Run
In design terms this was a randomized study.
Random assignment meant chance, not the researchers, decided who got MOTS-c and who got the comparison, which limits bias.
Muscle thickness by ultrasound, cross-sectional area by magnetic resonance imaging, circulating and skeletal muscle mitokine levels, and a series of skeletal muscle anabolism and atrophy markers were assessed before and after the 2-wk immobilization period.
What Was Measured
Topics PubMed links to this paper include Muscle, Skeletal, Immobilization, Fibroblast Growth Factors, Muscular Atrophy, Magnetic Resonance Imaging, Heat-Shock Response and Hot Temperature.
Author keywords: DISUSE MUSCLE ATROPHY, FGF21, HEAT STRESS, MITOKINES and MOTS-C.
What This Means in Plain Language
The paper is a randomized study of MOTS-c in 19 men.
With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.
Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.
The publication is from 2025 (Medicine and science in sports and exercise), a journal based in United States.
More context: the MOTS-c compound page, all human trials.
Our Notes on the Compound
MOTS-c: A 16-amino-acid peptide encoded in mitochondrial DNA.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.